{"transactions":[{"id":721197,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:30:27.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1299,"price":11.15,"value":14483.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":243752,"source":{"system":"sec-edgar","filing":"0001917165-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000006/primarydocument.xml","form_type":"4"}},{"id":858323,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:32:48.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":73340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":73340,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":73340},"source":{"system":"sec-edgar","filing":"0001917165-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000004/primarydocument.xml","form_type":"4"}},{"id":858322,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:32:48.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":50125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":242453,"source":{"system":"sec-edgar","filing":"0001917165-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000004/primarydocument.xml","form_type":"4"}},{"id":867059,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:01.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":17755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":192328,"source":{"system":"sec-edgar","filing":"0001917165-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000003/primarydocument.xml","form_type":"4"}},{"id":943193,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-01-08T21:21:25.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":108,"price":10.99,"value":1186.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025."}],"balance_after":174573,"source":{"system":"sec-edgar","filing":"0001917165-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000001/primarydocument.xml","form_type":"5"}},{"id":1097820,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:22.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":769,"price":15.13,"value":11634.97,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":174465,"source":{"system":"sec-edgar","filing":"0001562180-25-005185","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005185/primarydocument.xml","form_type":"4"}},{"id":1219531,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T21:42:00.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":81499,"price":18.19,"value":1482466.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":81499,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":81499},"source":{"system":"sec-edgar","filing":"0001562180-25-002162","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002162/primarydocument.xml","form_type":"4"}},{"id":1219530,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:42:00.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":54975,"price":18.19,"value":999995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":173696,"source":{"system":"sec-edgar","filing":"0001562180-25-002162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002162/primarydocument.xml","form_type":"4"}},{"id":1314721,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-01-03T21:04:29.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":669,"price":14.748,"value":9866.412,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2024 through December 31, 2024.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2024."}],"balance_after":118721,"source":{"system":"sec-edgar","filing":"0001562180-25-000067","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025000067/primarydocument.xml","form_type":"4"}},{"id":1439625,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-08-06T20:22:13.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":930,"price":12.24,"value":11383.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2024 through June 30, 2024.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2024."}],"balance_after":118052,"source":{"system":"sec-edgar","filing":"0001562180-24-006043","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024006043/primarydocument.xml","form_type":"4"}},{"id":1609989,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T21:30:37.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":125078,"price":16.3,"value":2038771.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy 125,078 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":125078,"derivative":{"exercise_price":16.3,"exercise_date":"2025-02-27","expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":125078},"source":{"system":"sec-edgar","filing":"0001562180-24-001982","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001982/primarydocument.xml","form_type":"4"}},{"id":1609988,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-29T21:30:37.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":81799,"price":16.3,"value":1333323.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":117122,"source":{"system":"sec-edgar","filing":"0001562180-24-001982","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001982/primarydocument.xml","form_type":"4"}},{"id":1609987,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-29T21:30:37.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":128,"price":12.69,"value":1624.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2023 through December 31, 2023.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2023."}],"balance_after":35323,"source":{"system":"sec-edgar","filing":"0001562180-24-001982","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001982/primarydocument.xml","form_type":"4"}},{"id":1833830,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-07-06T20:13:47.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":288,"price":35.28,"value":10160.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January1, 2023 through June 30, 2023.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023."}],"balance_after":35195,"source":{"system":"sec-edgar","filing":"0001562180-23-005758","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023005758/primarydocument.xml","form_type":"4"}},{"id":1979486,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-03-02T21:56:59.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":29531,"price":76.97,"value":2273001.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 29,531 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":29531,"derivative":{"exercise_price":76.97,"exercise_date":"2024-02-28","expiration_date":"2033-02-27","underlying":"Ordinary Shares","underlying_shares":29531},"source":{"system":"sec-edgar","filing":"0001645113-23-000028","document":"wf-form4_167779418753921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000028/wf-form4_167779418753921.xml","form_type":"4"}},{"id":1979485,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-03-02T21:56:59.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":17755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":34907,"source":{"system":"sec-edgar","filing":"0001645113-23-000028","document":"wf-form4_167779418753921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000028/wf-form4_167779418753921.xml","form_type":"4"}},{"id":2057505,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-01-10T21:20:50.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":150,"price":62.305,"value":9345.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2022 through December 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022."}],"balance_after":17152,"source":{"system":"sec-edgar","filing":"0001645113-23-000015","document":"wf-form4_167338563438202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000015/wf-form4_167338563438202.xml","form_type":"4"}},{"id":2210749,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:50:17.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":144,"price":59.075,"value":8506.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2022 through June 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022."}],"balance_after":17002,"source":{"system":"sec-edgar","filing":"0001645113-22-000065","document":"wf-form4_165723060256540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000065/wf-form4_165723060256540.xml","form_type":"4"}}]}